(Q44809014)

6 December 2017

title

YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection (English)

1 reference

Leonardo de Lucca Schiavon

6 December 2017

1 reference

1

1 reference

6 December 2017

Roberto Carvalho-Filho

2

1 reference

Janaína L Narciso-Schiavon

6 December 2017

3

1 reference

6 December 2017

author name string

José O Medina-Pestana

4

1 reference

6 December 2017

Valéria P Lanzoni

5

1 reference

6 December 2017

Maria Lucia G Ferraz

6

1 reference

6 December 2017

Antonio Eduardo B Silva

7

1 reference

6 December 2017

publication date

1 May 2010

1 reference

Scandinavian Journal of Gastroenterology

6 December 2017

published in

1 reference

6 December 2017

volume

45

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

615-622

1 reference

Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Impact of hepatitis B and C virus on kidney transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Serum hyaluronan as a disease marker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Chronic renal allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Evaluation of hepatitis B and hepatitis C virus-infected renal allograft recipients with liver biopsy and noninvasive parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Liver biopsy size matters in chronic hepatitis: bigger is better

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521003637203

10.3109/00365521003637203

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference